CD44 expression on epidermal melanocytes

Journal of Investigative Dermatology

Volumn 106, Issue 6, 1996, Pages 1230-1235

  Herbold, Kyle W ^b   Zhou, Jing ^b   Haggerty, John G ^b   Milstone, Leonard M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

adhesion; keratinocyte; prosteoglycan; tetradecanoyl phorbol acetate (TPA)

Indexed keywords

HERMES ANTIGEN; PHORBOL ESTER;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MALE; MELANOCYTE; MELANOMA; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029883244     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12348871     Document Type: Article

References (47)

1. Arch R, Wirth K, Hoffmann M, Ponta H, Marzku S, Herrlick P, Zöller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682-685, 1992
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CH, Seed H: CD44 is the principal cell surface receptor for hyaluronate. Cell 61 : 1303-1313, 1990
3. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180:53-66, 1994
4. Brown TA, Bouchard T, St John T, Wayner F, Carter WG: Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207-221, 1991
5. Birch M, Mitchell S, Hart IR: Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51:6660-6667, 1991
6. 133 kinase in human melanocytes. Cell Growth Differ 6:291-302, 1995
7. Camp RL, Kraus TA, Puré E: Variations in the cytoskeletal interaction and post-translational modification of the CD44 homing receptor in macrophages. J Cell Biol 115:1283-1292, 1991
8. Carter WG, Wayner EA: Characterization of the Class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263:4193-4201, 1988
9. Dougherty G, Lansdorp PM, Cooper DL, Humphries RK: Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte 'homing' receptor expressed by hematopoietic cells. J Exp Med 174;1-5, 1991
10. East JA, Mitchell SD, Hart IR: Expression and function of the CH44 glycoprotein in melanoma cell lines. Melanoma Res 3:341-346, 1993
11. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB: A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type 1 collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531, 1992
12. Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB: Cell surface CD44-related chondroitin sultate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell niotility and invasive behavior on type I collagen. J Cell Sci 105:501-511, 1993
13. Funasaka Y, Boulton T, Cobb M, Yarden Y, Fan B, Lyman SD, Williams DE, Anderson DM, Zakut R, Mishima Y, Halaban R: c-Kit induces a cascade of protein tyrosine-phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down regulated in melanomas. Mol Biol Cell 3:197-209, 1992
14. Günthert U, Hoffmann M, Rudy W, Reber S, Zöller M, Haussman I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991
15. Guo Y, Ma I, Wang J, Che X, Narula J, Bigby M, Wu M, Sy M-S: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibodies. Cancer Res 54:1561-1565, 1994
16. Haggerty JG, Bretton RH, Milstone LM: Identification and characterization of a cell surface proteoglycan on keratinocytes. J Invest Dermatol 90:374-380, 1992
17. Haggerry JG, Bretton RH, Milstone LM: Response of stratified cultures of human keratinocytes to disruption of prou-oglycan synthesis by p-nitrophenyl-β-D-xylopyranoside. J Cell Physiol 158:39-46, 1994
18. Halaban R, Ruhin J, Punasaka Y, Cobb M, Boulton T, Faletto D, Rosen K, Chan A, Yoko K, White W, Cook C, Moellmann G: Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2105-2206, 1992
19. Hara M, Yaar M, Tang A, Eller MS, Reenstra W, Gilchrest BA: Role of integrins in melanocyte attachment and dendricity. J Cell Sci 107:2739-2748, 1994
20. Harlow E, Lane D (eds.): Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, 1988, pp 522-525
21. Hart IR, Birch M, Marshall JF. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 10:115-128, 1991
22. He Q, Lesley J, Hyman R, Ishihara K, Kincade PW: Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 110:1711-1719, 1992
23. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995
24. Jalkanen M, Nguyen H, Rapraeger A, Kurn N, Bernfield M: Heparan sulfate proteoglycan from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody. J Cell Biol 101:976-984, 1985
25. Jalkanen S, Bargatze RF, Toyos J, Butcher KC: Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983-990, 1987
26. Jalkanen S, Jalkanen M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817-825, 1992
27. Jalkanen S, Jalkanen M, Bargatze R, Tanuni M, Butcher F: Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 141:1615-1623, 1988
28. Kato M, Oike Y, Suzuk S, Kimata K: Selective removal of heparan sulfate chains from proteoheparan sulfate with a commercial preparation of Heparitinase. Anal Biochem 148:479-484, 1985
29. Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM: The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an alternative form of CD44. J Invest Dermatol 99:887-891, 1992
30. Matsumura Y, Tarin D: Significance of CD44 gone products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058, 1992
31. Miettinen HM, Jalkanen M: The cytoplasmic domain of syndecan-1 is not required for association with Triton X-100-insoluble material. J Cell Sci 107:1571-1581, 1994
32. Milstone LM, Hough-Monroe L, Kugelman LC, Bender JR, Haggerty JG: Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J Cell Sci 107:3183-3190, 1994
33. Oike Y, Kimata K, Shinomura T, Nakazawak K, Suzuki S: Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-β-D-galactosidase (keratanase). Biochem J 191:193-207, 1980
34. Peipkorn M, Fleckman P, Carney H, Hovingh F, Linker A: The distinctive pattern of proteoglycan and glycosaminoglycan free chain synthesis by cultured human epidermal keratinocytes. J Invest Dermatol 94:107-113, 1990
35. St John T, Meyer J, Idzerda R, Gallatin WM: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60:43-52, 1990
36. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S: Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431-442, 1993
37. Shimizu Y, Van Seventer GA, Siriganian R, Wohl L, Shaw S: Dual role of CD44 molecule in T cell adhesion and activation. J Immunol 143:2457-2463, 1989
38. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348, 1991
39. Sy MS, Guo Y-J, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859-866, 1991
40. Tammi R, Ripellino JA, Margolis RU, Tammi M: Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as specific probe. J Invest Dermatol 90:412-414, 1988
41. Thomas L, Byers HR, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118:971-977, 1992
42. Thomas L, Etoh T, Stamenkovic I, Mihm MC Jr, Byers HR: Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 100:115-120, 1993
43. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
44. van Muijen GNP, Danen EHJ, Veerkamp JH, Ruiter DJ, Lesley J, van den Heuvel LPWJ: Glycoconjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 61:241-248, 1995
45. van Weering DHJ, Baas PD, Bos JL: A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3:100-106, 1993
46. Zhang L, Underhill CB, Chen L: Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55:428-433, 1995
47. Zambruno G, Marchisio PC, Melchiori A, Bondanza S, Cancedda R, De Luca M: Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes. J Cell Sci 105:179-190, 1993